You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tazemetostat

Showing 26 - 40 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma Trial in Tucson, Tampa, New York

Completed
Has Results
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Tazemetostat
  • +3 more
  • Tucson, Arizona
  • +2 more
Mar 23, 2021

Advanced Soft Tissue Sarcoma, Advanced Epithelioid Sarcoma Trial in Worldwide (Tazemetostat, Placebo, Doxorubicin HCl)

Recruiting
  • Advanced Soft Tissue Sarcoma
  • Advanced Epithelioid Sarcoma
  • Tazemetostat
  • +2 more
  • Duarte, California
  • +20 more
Jan 31, 2022

Follicular Lymphoma, Non Hodgkin Lymphoma, Lymphoma Trial in Edmonds, Issaquah, Seattle (Tazemetostat, Rituximab)

Terminated
  • Follicular Lymphoma
  • +2 more
  • Edmonds, Washington
  • +2 more
Mar 1, 2021

Lymphoma, DLBCL, Follicular Lymphoma Trial in Belgium, France (Tazemetostat, Rituximab, Cyclophosphamide)

Recruiting
  • Lymphoma
  • +2 more
  • Tazemetostat
  • +5 more
  • Bruxelles, Belgium
  • +30 more
Jul 23, 2021

Mesothelioma, BAP1 Loss of Function Trial in France, United Kingdom, United States (Tazemetostat)

Completed
Has Results
  • Mesothelioma
  • BAP1 Loss of Function
  • Tazemetostat
  • Los Angeles, California
  • +15 more
Mar 16, 2021

Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6

Not yet recruiting
  • Grade 3b Follicular Lymphoma
  • +5 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 6, 2023

Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

Completed
  • Rhabdoid Tumors
  • +3 more
  • Tazemetostat
  • Los Angeles, California
  • +34 more
Dec 23, 2021

Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +9 more
Oct 24, 2022

Epithelioid Sarcoma Trial (Tazemetostat)

No longer available
  • Epithelioid Sarcoma
  • Tazemetostat
  • (no location specified)
Mar 4, 2020

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Tazemetostat
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma

Active, not recruiting
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Tazemetostat
  • Anchorage, Alaska
  • +584 more
Jan 28, 2023

Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma, Metastatic Malignant Solid

Withdrawn
  • Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma
  • +10 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Feb 6, 2020

Lymphoma Trial in Worldwide (Atezolizumab, Obinutuzumab, Tazemetostat)

Completed
  • Lymphoma
  • Duarte, California
  • +14 more
Jan 22, 2020

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +86 more
Jan 23, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023